| 1 |
-
From gut to liver: Exploring the relationship between inflammatory bowel disease and metabolic dysfunction-associated steatotic liver disease
-
9/25/2025 11:24:04 AM | Browse: 65 | Download: 0
|
| 2 |
-
Extracellular vesicles in metabolic dysfunction-associated steatotic liver disease: From intercellular signaling to clinical translation
-
9/25/2025 11:24:01 AM | Browse: 57 | Download: 0
|
| 3 |
-
Silymarin-alpha lipoic acid and metabolic dysfunction-associated steatotic liver disease: Insights and methodological considerations
-
9/25/2025 11:24:00 AM | Browse: 55 | Download: 0
|
| 4 |
-
Nutrients as epigenetic modulators in metabolic dysfunction-associated steatotic liver disease
-
8/27/2025 9:21:11 AM | Browse: 103 | Download: 142
|
| 5 |
-
Myths and facts about the role of diet in metabolic dysfunctionassociated steatotic liver disease
-
8/27/2025 9:21:10 AM | Browse: 88 | Download: 152
|
| 6 |
-
Skeletal muscle alterations in metabolic dysfunction-associated steatotic liver disease: A critical review of diagnostic, mechanistic, and therapeutic intersections
-
8/18/2025 10:04:52 AM | Browse: 24 | Download: 68
|
| 7 |
-
Poor sleep and hepatic steatosis contribute to poorer quality of life in people with human immunodeficiency virus
-
8/5/2025 8:25:47 AM | Browse: 23 | Download: 112
|
| 8 |
-
Role of mac-2 binding protein glycosylation isomer in predicting fibrosis in patients with metabolic dysfunction-associated steatotic liver disease
-
7/25/2025 12:09:41 PM | Browse: 40 | Download: 156
|
| 9 |
-
Metabolic dysfunction-associated steatotic liver disease: Mechanisms, metabolic reprogramming, and therapeutic insights
-
7/11/2025 7:47:41 AM | Browse: 27 | Download: 122
|
| 10 |
-
Multiparametric ultrasound for non-invasive assessment of liver steatosis, fibrosis and inflammation in metabolic dysfunction-associated steatotic liver disease
-
7/4/2025 9:23:53 AM | Browse: 47 | Download: 197
|
| 11 |
-
Extracellular vesicles as biomarkers for metabolic dysfunction-associated steatotic liver disease staging using explainable artificial intelligence
-
6/12/2025 3:45:50 AM | Browse: 35 | Download: 234
|
| 12 |
-
Metabolic dysfunction-associated steatotic liver disease: A story of muscle and mass
-
5/28/2025 7:32:57 AM | Browse: 37 | Download: 215
|
| 13 |
-
Association between weight fluctuation and the risk of metabolic dysfunction-associated steatotic liver disease
-
5/27/2025 7:04:47 AM | Browse: 26 | Download: 248
|
| 14 |
-
Open questions on how metabolic dysfunction-associated steatotic liver disease shapes the course of drug-induced liver injury
-
5/27/2025 7:04:45 AM | Browse: 20 | Download: 178
|
| 15 |
-
Bicuculline ameliorates metabolic dysfunction-associated steatotic liver disease by inhibiting the nuclear factor-kappa B pathway and reducing lipid accumulation
-
4/29/2025 9:13:41 AM | Browse: 42 | Download: 298
|
| 16 |
-
Metabolic dysfunction-associated steatotic liver disease and omega-6 polyunsaturated fatty acids: Friends or foes
-
3/26/2025 4:06:55 AM | Browse: 35 | Download: 206
|
| 17 |
-
Gut microbiota differences, metabolite changes, and disease intervention during metabolic - dysfunction - related fatty liver progression
-
3/26/2025 4:06:51 AM | Browse: 37 | Download: 190
|
| 18 |
-
Attenuation imaging: Diagnostic differences in hepatic steatosis for chronic hepatitis B vs metabolic dysfunction-associated steatotic liver disease patients
-
3/13/2025 10:11:05 AM | Browse: 61 | Download: 269
|
| 19 |
-
Mitochondrial mt12361A > G increased risk of metabolic dysfunction-associated steatotic liver disease among non-diabetes
-
2/26/2025 4:21:41 AM | Browse: 39 | Download: 336
|
| 20 |
-
Heart failure with preserved ejection fraction and metabolic dysfunction-associated steatotic liver disease: Twin challenges, one metabolic solution
-
2/25/2025 6:14:40 AM | Browse: 49 | Download: 207
|
| 21 |
-
Metabolic dysfunction-associated steatotic liver disease and type 2 diabetes: A dual threat to cardiac dysfunction progression
-
1/21/2025 6:56:33 AM | Browse: 41 | Download: 189
|
| 22 |
-
Inhibition of metabotropic glutamate receptor-5 alleviates hepatic steatosis by enhancing autophagy via activation of the AMPK signaling pathway
-
1/20/2025 7:38:46 AM | Browse: 36 | Download: 295
|
| 23 |
-
Fanlian Huazhuo Formula: A promising herbal preparation for metabolic liver disease
-
11/21/2024 7:04:50 AM | Browse: 74 | Download: 265
|
| 24 |
-
Interplay of gut microbiota, glucagon-like peptide receptor agonists, and nutrition: New frontiers in metabolic dysfunction-associated steatotic liver disease therapy
-
10/31/2024 10:42:49 AM | Browse: 70 | Download: 297
|
| 25 |
-
Statins decrease the risk of hepatocellular carcinoma in metabolic dysfunction-associated steatotic liver disease: A systematic review and meta-analysis
-
10/31/2024 7:40:52 AM | Browse: 63 | Download: 364
|
| 26 |
-
Metabolic dysfunction-associated steatotic liver disease-associated fibrosis and cardiac dysfunction in patients with type 2 diabetes
-
10/17/2024 2:38:59 PM | Browse: 62 | Download: 414
|
| 27 |
-
Hepatic angiotensin-converting enzyme 2 expression in metabolic dysfunction-associated steatotic liver disease and in patients with fatal COVID-19
-
8/13/2024 8:00:24 AM | Browse: 79 | Download: 395
|
| 28 |
-
Role of incretins and glucagon receptor agonists in metabolic dysfunction-associated steatotic liver disease: Opportunities and challenges
-
5/22/2024 11:33:24 AM | Browse: 79 | Download: 376
|
| 29 |
-
Gestational diabetes mellitus may predispose to metabolic dysfunction-associated steatotic liver disease
-
5/22/2024 11:33:24 AM | Browse: 76 | Download: 338
|
| 30 |
-
FibroScan-aspartate transaminase: A superior non-invasive model for diagnosing high-risk metabolic dysfunction-associated steatohepatitis
-
5/11/2024 10:58:28 AM | Browse: 102 | Download: 580
|
| 31 |
-
Metabolic dysfunction-associated steatotic liver disease: Navigating terminological evolution, diagnostic frontiers and therapeutic horizon-an editorial exploration
-
5/11/2024 10:58:27 AM | Browse: 83 | Download: 371
|
| 32 |
-
Disparate outcomes in Hispanic patients with metabolic dysfunction-associated steatotic liver disease/steatohepatitis and type 2 diabetes: Large cohort study
-
5/10/2024 11:51:40 AM | Browse: 110 | Download: 694
|
| 33 |
-
Omics-based biomarkers as useful tools in metabolic dysfunction-associated steatotic liver disease clinical practice: How far are we?
-
4/12/2024 4:45:44 PM | Browse: 112 | Download: 483
|
| 34 |
-
Recent advances in age-related metabolic dysfunction-associated steatotic liver disease
-
2/21/2024 9:11:33 AM | Browse: 171 | Download: 670
|
